{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:55:27Z","timestamp":1792418127735,"version":"4.4.0"},"reference-count":34,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2016,4,2]]},"DOI":"10.3109\/10428194.2015.1085528","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T23:28:38Z","timestamp":1444346918000},"page":"852-865","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Systematic review of the recent evidence for the efficacy and safety of chlorambucil in the treatment of B-cell malignancies"],"prefix":"10.3109","volume":"57","author":[{"given":"St\u00e9phane","family":"Lepretre","sequence":"first","affiliation":[{"name":"Service d\u2019h\u00e9matologie, centre de lutte contre le cancer, Henri Becquerel","place":["Rouen, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dartigeas","sequence":"additional","affiliation":[{"name":"Service de canc\u00e9rologie et d\u2019h\u00e9matologie th\u00e9rapie cellulaire, CHU Bretonneau","place":["Tours, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Feugier","sequence":"additional","affiliation":[{"name":"Service h\u00e9matologie, CHU Nancy Brabois, Vandoeuvre Les Nancy","place":["Nancy, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marty","sequence":"additional","affiliation":[{"name":"Nukleus, d\u00e9partement recherche clinique","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Salles","sequence":"additional","affiliation":[{"name":"Service d\u2019h\u00e9matologie, Hospices civils de Lyon, Centre hospitalier Lyon Sud","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23979"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.8262"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.963077"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.04.007"},{"key":"e_1_3_2_9_1","first-page":"2723","article-title":"Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial","volume":"96","author":"Robak T","year":"2000","unstructured":"Robak T, Blo\u0144ski JZ, Kasznicki M, et al. Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. Blood 2000; 96: 2723\u20132729.","journal-title":"Blood"},{"key":"e_1_3_2_10_1","first-page":"PI71","article-title":"Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1)","volume":"11","author":"Roback T","year":"2005","unstructured":"Roback T, Blo\u0144ski JZ, Kasznicki M, et al. Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1). Med Sci Monit 2005; 11: PI71\u201379.","journal-title":"Med Sci Monit"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61125-8"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9098"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206185"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8389"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12000"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","unstructured":"Hillmen P Robak T Janssens A et\u00a0al. Ofatumumab\u2009+\u2009chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukemia (CLL): results of the phase III study complement 1 (OMB110911). Blood (Suppl) 2013; 122: 528.","DOI":"10.1182\/blood.V122.21.528.528"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.893306"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012143432402"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14110-4"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22093"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07486.x"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.6272"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7920"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.11.004"},{"key":"e_1_3_2_27_1","first-page":"1164","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial","volume":"37","author":"Allek M","year":"2010","unstructured":"Allek M, Fischer K, Fingerle-Rowson G, et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010; 37: 1164\u20131174.","journal-title":"Lancet"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2161-6"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1110"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.0866"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.100"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-565135"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23472"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.031"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.1530"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1085528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/10428194.2015.1085528","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1085528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:31:47Z","timestamp":1792416707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2015.1085528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4,2]]}},"alternative-id":["10.3109\/10428194.2015.1085528"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2015.1085528","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}